Johnson & Johnson Executive Compensation
Johnson & Johnson is an American multinational corporation that develops medical devices, pharmaceuticals, and consumer goods.
Named Executive Officers — FY2025
Compensation Analysis
Computed directly from SEC-sourced figures tracked on this page — not a general description.
Johnson & Johnson discloses FY2025 compensation for 5 named executive officers, totaling $57.9M. Joaquin Duato, the Chairman & CEO, accounts for 39% of that combined total.
Joaquin Duato's total compensation fell 7% year-over-year, from $24.3M in FY2024 to $22.6M in FY2025.
Cash compensation (salary plus bonus) made up 11% of Johnson & Johnson's FY2025 tracked executive pay, with stock awards accounting for 0%.
Among 78 other Healthcare companies in this dataset, Johnson & Johnson's combined tracked executive pay of $57.9M ranks in the 97th percentile (industry median: $12.5M). Its highest-paid executive, Joaquin Duato, ranks in the 91th percentile for top-executive pay in the sector (industry median: $6.0M).
Compensation figures on this page for Johnson & Johnson come directly from its SEC DEF 14A proxy statement(s), filed with the SEC via EDGAR — not from crowdsourced or self-reported salary data.